D.1 SCHEDULE OF SERVICES.xlsx
XLSX spreadsheet 68 KB Posted
- Attached to
- Q301--STAT REFERENCE LABORATORY SERVICES - FARGO Federal contract opportunity
- Solicitation number
- 36C26324Q0426
About this file
This document includes a solicitation for reference laboratory testing services. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 is seeking an indefinite quantity contract for anatomic pathology reference laboratory services to support the Fargo ND VA Health Care System located at 2101 Elm Street North, Fargo ND 58102. The period of performance is from April 1, 2024 to March 31, 2029. Services include flow cytometry, cytogenetics, fluorescence in situ hybridization, anatomical pathology, and molecular pathology testing as described in the attached schedule of services. Questions regarding the solicitation are due by February 27, 2024. Offers must be submitted to the contracting office by March 4, 2024. Evaluation will be based on lowest price technically acceptable.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C26324Q0426 0001_1.docx | DOCX document | |
| 36C26324Q0426 0001.pdf | ||
| D.4 WAGE DETERMINATION 2015-4969.pdf | ||
| D.3 ORGANIZATIONAL CONFLICT CERTIFICATE.pdf | ||
| D.2 IMMIGRATION CERTIFICATION.pdf | ||
| 36C26324Q0426.pdf | ||
| 36C26324Q0426_1.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Order Period 1
| Order Period 1: 04/01/2024-03/31/2025 | |||||
| Test Name | CPT/s | Units | Estimated Quantity | Unit Price | Total Est Price |
FLOW CYTOMETRY
| 10 COLOR FLOW CYTOMETRY | ||||||
| 10 Color Flow Cytometry - General Pricing | ||||||
| TC Flow Cytometry 1st marker | 88184 | 1 | 100 | $ - 0 | ||
| Additional Markers | 88185 | 23 | 50 | $ - 0 | *Standard Panel has 23 additional markers, so this should be taken into consideration when calculating | |
| Flow Interpretation (2-8 Markers) | 88187 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (9-15 Markers) | 88188 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (16+ Markers) | 88189 | 1 | 50 | $ - 0 | ||
| $ - 0 | ||||||
| 10 Color Flow Cytometry Special Pricing | $ - 0 | |||||
| Flow Profile PNH Tech (8) | 88184, 88185 | 8 | 1 | $ - 0 | ||
| Flow Profile DNA Global | 88182 | 1 | 1 | $ - 0 | ||
| $ - 0 | ||||||
| $ - 0 | ||||||
| CYTOGENETICS | $ - 0 | |||||
| Chromosome Analysis (Set Up) | 88237 or 88230 or 88233 or 88239 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis (Cell Analysis) | 88261, 88262, or 88264 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis Interpretation | 88291 | 1 | 1 | $ - 0 | ||
| Additional Karyotypes | 88280 | 1 | 1 | $ - 0 | ||
| Additional Cells | 88285 | 1 | 1 | $ - 0 | ||
| Additional Culture | 88237 or 88239 | 1 | 1 | $ - 0 | ||
| No Growth | 88230, 88233, 88237, or 88239 | 1 | 1 | $ - 0 | ||
| FISH | $ - 0 | |||||
| MANUAL | $ - 0 | |||||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | 88368PC | 5 | $ - 0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | 88368TC | 5 | $ - 0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | 88368 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | 88369TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 88369PC | 5 | $ - 0 | |||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | 88369 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | 88377TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | 88377PC | 5 | $ - 0 | |||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | 88377 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| AUTOMATED | $ - 0 | |||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | 88367TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | 88367PC | 5 | $ - 0 | |||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | 88367 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | 88373TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | 88373PC | 5 | $ - 0 | |||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | 88373 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | 88374TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | 88374PC | 5 | $ - 0 | |||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | 88374 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| $ - 0 | ||||||
| ANATOMIC PATHOLOGY (3) | $ - 0 | |||||
| Special Stain | 88312 | 10 | $ - 0 | |||
| Special Stain Tech | 88312TC | 10 | $ - 0 | |||
| Tissue Special Stain | 88313 | 10 | $ - 0 | |||
| Tissue Special Stain Tech | 88313TC | 10 | $ - 0 | |||
| Professional Consult | 88323 | 5 | $ - 0 | |||
| Professional Consult Tech | 88323TC | 5 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure | 88341 | 10 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure Tech | 88341TC | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain | 88342 | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain Tech | 88342TC | 10 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | 88360 | 1 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | 88360TC | 1 | $ - 0 | |||
| IHC Quantitative | 88360 | 10 | $ - 0 | |||
| IHC Quantitative Tech | 88360TC | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Glo | 88361 | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Tech | 88361TC | 10 | $ - 0 | |||
| IHC by ISH | 88365/ 88364 | 10 | $ - 0 | |||
| IHC by ISH TC | 88365TC/ 88364TC | 10 | $ - 0 | |||
| MOLECULAR PATHOLOGY TESTING (3) | $ - 0 | |||||
| ALK Mutation Analysis | 81479 | 1 | $ - 0 | |||
| BCR-ABL1 Standard p210,p190 | 81479 | 5 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Major (p210) for CML | 81206 | 1 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Minor (p210) for ALL | 81207 | 1 | $ - 0 | |||
| BCR-ABL1 Non-Standard p230 | 81208 | 1 | $ - 0 | |||
| T-Cell Receptor Beta Gene Rearrangement | 81340 | 1 | $ - 0 | |||
| B&T-Cell Gene Rearrangement (Fragment Length Analysis) | 81479 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGH | 81261 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGK | 81264 | 1 | $ - 0 | |||
| T-Cell Receptor Gamma Gene Rearrangement | 81342 | 1 | $ - 0 | |||
| BCL-1 Translocation t(11:14) | 81168 | 1 | $ - 0 | |||
| BCL-2 Translocation t(14;18) | 81278 | 1 | $ - 0 | |||
| BRAF Mutation Analysis (Bi-directional Sequencing) | 81210 | 1 | $ - 0 | |||
| Brain NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BRCA1/2 Mutation Analysis for Tumors | 81163 | 1 | $ - 0 | |||
| Breast NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BTK Mutation Analysis (single gene assay) | 81233 | 1 | $ - 0 | |||
| BTK Inhibitor Acquired Resistance Panel | 81479 | 1 | $ - 0 | |||
| CEBPA Mutation Analysis (Bi-directional Sequencing) | 81218 | 1 | $ - 0 | |||
| KIT (c-KIT) Mutation Analysis | 81272 | 1 | $ - 0 | |||
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Colorectal NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| CXCR4 Mutation Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| EGFR Mutation Analysis (Bi-directional Sequencing) | 81235 | 1 | $ - 0 | |||
| EGFR vIII Analysis | 81479 | 1 | $ - 0 | |||
| ERBB2 Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| FLT3 (ITD & IKD) Mutation Analysis | 81479 | 1 | $ - 0 | |||
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | 81246 | 1 | $ - 0 | |||
| IDH1 and IDH2 Mutations Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| IgVH Mutation Analysis | 81263 | 1 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 10 | $ - 0 | |||
| JAK2 V617F with reflex to EXON 12-14 Mutation Analysis (Bi-Directional Seq) | 81270, 81279 | 10 | $ - 0 | |||
| KRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Lung Complete NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Lung Limited NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| MET Exon 14 Deletion Analysis | 81479 | 1 | $ - 0 | |||
| MicroSatellite Instability Analysis (MSI)(Fragment Length Analysis) | 81301 | 1 | $ - 0 | |||
| MLH1 Promoter Methylation Analysis | 81288 | 1 | $ - 0 | |||
| MPN Extended Reflex Panel | 81479 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 5 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 5 | $ - 0 | |||
| CALR Mutation Analysis | 81219 | 1 | $ - 0 | |||
| MPL Mutation Analysis (Bi-directional Sequencing) | 81339 | 2 | $ - 0 | |||
| NTRK NGS Fusion Panel | 81194 | 1 | $ - 0 | |||
| NTRK & RET NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| Non-Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| NOTCH1 Mutation Analysis (Fragment Length Analysis) | 81407 | 1 | $ - 0 | |||
| NPM1 Mutation Analysis (Fragment Length Analysis) | 81310 | 1 | $ - 0 | |||
| NRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| PML-RARA Translocation, t(15;17) | 81315 | 1 | $ - 0 | |||
| Prostate NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| RAS/RAF Panel | 81479 | 1 | $ - 0 | |||
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | 81401 | 1 | $ - 0 | |||
| Sarcoma Comprehensive NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| STAT3 Mutation Analysis | 81405 | 1 | $ - 0 | |||
| Targeted Solid Tumor NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Thyroid NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| TP53 Mutation Analysis (Bi-Directional Sequencing) | 81352 | 1 | $ - 0 | |||
| Universal Solid Tumor NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| $ - 0 | ||||||
| 1 | $ - 0 | |||||
| Hematologic Profiles (Molecular Only) | $ - 0 | |||||
| NeoTYPE™ ALL Prognostic Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Discovery Profile for Hematologic Cancers | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Follicular Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Lymphoid Disorders Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| NeoTYPE™ Cholangiocarcinoma Profile | 81445 1 | 1 | $ - 0 | |||
| NeoTYPE Lung Tumor Profile | 81479 1 | 1 | $ - 0 | |||
| NeoTYPETM (or equivalent) Global | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE CLL Prognostic Profile | 81479, 88374x4 | 1 | $ - 0 | |||
| NeoTYPE ALL Profile | 81450, 88374x2 | 1 | $ - 0 | |||
| NeoTYPE™ Myeloid Disorders Profile | 81455 | 1 | $ - 0 | Global Only, replaces Myeloid Disorders Profile | ||
| NeoTYPE MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoTYPETM (4) (or equivalent) Technical Only | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE ALL Profile | 81450, 88374TCx2 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoLABTM (or equivalent) LIQUID BIOPSY | $ - 0 | |||||
| $ - 0 | ||||||
| SPECIMEN HOLD OPTIONS | $ - 0 | |||||
| Cytogenetics | $ - 0 | |||||
| Culture and Hold | 1 | $ - 0 | ||||
| FISH | $ - 0 | |||||
| Direct Harvest and Hold for FISH | 1 | $ - 0 | ||||
| Molecular Testing | $ - 0 | |||||
| Freeze and Hold | 1 | $ - 0 | ||||
| Extract Nucleic Acid and Hold | 1 | $ - 0 |
| Miscellanous Testing - not listed above | |
| TOTAL | |
| $ - 0 |
Order Period 2
| Order Period 2: 04/01/2025-03/31/2026 | |||||
| Test Name | CPT/s | Units | Estimated Quantity | Unit Price | Total Est Price |
FLOW CYTOMETRY
| 10 COLOR FLOW CYTOMETRY | ||||||
| 10 Color Flow Cytometry - General Pricing | ||||||
| TC Flow Cytometry 1st marker | 88184 | 1 | 100 | $ - 0 | ||
| Additional Markers | 88185 | 23 | 50 | $ - 0 | *Standard Panel has 23 additional markers, so this should be taken into consideration when calculating | |
| Flow Interpretation (2-8 Markers) | 88187 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (9-15 Markers) | 88188 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (16+ Markers) | 88189 | 1 | 50 | $ - 0 | ||
| $ - 0 | ||||||
| 10 Color Flow Cytometry Special Pricing | $ - 0 | |||||
| Flow Profile PNH Tech (8) | 88184, 88185 | 8 | 1 | $ - 0 | ||
| Flow Profile DNA Global | 88182 | 1 | 1 | $ - 0 | ||
| $ - 0 | ||||||
| $ - 0 | ||||||
| CYTOGENETICS | $ - 0 | |||||
| Chromosome Analysis (Set Up) | 88237 or 88230 or 88233 or 88239 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis (Cell Analysis) | 88261, 88262, or 88264 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis Interpretation | 88291 | 1 | 1 | $ - 0 | ||
| Additional Karyotypes | 88280 | 1 | 1 | $ - 0 | ||
| Additional Cells | 88285 | 1 | 1 | $ - 0 | ||
| Additional Culture | 88237 or 88239 | 1 | 1 | $ - 0 | ||
| No Growth | 88230, 88233, 88237, or 88239 | 1 | 1 | $ - 0 | ||
| FISH | $ - 0 | |||||
| MANUAL | $ - 0 | |||||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | 88368PC | 5 | $ - 0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | 88368TC | 5 | $ - 0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | 88368 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | 88369TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 88369PC | 5 | $ - 0 | |||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | 88369 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | 88377TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | 88377PC | 5 | $ - 0 | |||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | 88377 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| AUTOMATED | $ - 0 | |||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | 88367TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | 88367PC | 5 | $ - 0 | |||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | 88367 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | 88373TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | 88373PC | 5 | $ - 0 | |||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | 88373 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | 88374TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | 88374PC | 5 | $ - 0 | |||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | 88374 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| $ - 0 | ||||||
| ANATOMIC PATHOLOGY (3) | $ - 0 | |||||
| Special Stain | 88312 | 10 | $ - 0 | |||
| Special Stain Tech | 88312TC | 10 | $ - 0 | |||
| Tissue Special Stain | 88313 | 10 | $ - 0 | |||
| Tissue Special Stain Tech | 88313TC | 10 | $ - 0 | |||
| Professional Consult | 88323 | 5 | $ - 0 | |||
| Professional Consult Tech | 88323TC | 5 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure | 88341 | 10 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure Tech | 88341TC | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain | 88342 | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain Tech | 88342TC | 10 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | 88360 | 1 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | 88360TC | 1 | $ - 0 | |||
| IHC Quantitative | 88360 | 10 | $ - 0 | |||
| IHC Quantitative Tech | 88360TC | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Glo | 88361 | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Tech | 88361TC | 10 | $ - 0 | |||
| IHC by ISH | 88365/ 88364 | 10 | $ - 0 | |||
| IHC by ISH TC | 88365TC/ 88364TC | 10 | $ - 0 | |||
| MOLECULAR PATHOLOGY TESTING (3) | $ - 0 | |||||
| ALK Mutation Analysis | 81479 | 1 | $ - 0 | |||
| BCR-ABL1 Standard p210,p190 | 81479 | 5 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Major (p210) for CML | 81206 | 1 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Minor (p210) for ALL | 81207 | 1 | $ - 0 | |||
| BCR-ABL1 Non-Standard p230 | 81208 | 1 | $ - 0 | |||
| T-Cell Receptor Beta Gene Rearrangement | 81340 | 1 | $ - 0 | |||
| B&T-Cell Gene Rearrangement (Fragment Length Analysis) | 81479 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGH | 81261 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGK | 81264 | 1 | $ - 0 | |||
| T-Cell Receptor Gamma Gene Rearrangement | 81342 | 1 | $ - 0 | |||
| BCL-1 Translocation t(11:14) | 81168 | 1 | $ - 0 | |||
| BCL-2 Translocation t(14;18) | 81278 | 1 | $ - 0 | |||
| BRAF Mutation Analysis (Bi-directional Sequencing) | 81210 | 1 | $ - 0 | |||
| Brain NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BRCA1/2 Mutation Analysis for Tumors | 81163 | 1 | $ - 0 | |||
| Breast NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BTK Mutation Analysis (single gene assay) | 81233 | 1 | $ - 0 | |||
| BTK Inhibitor Acquired Resistance Panel | 81479 | 1 | $ - 0 | |||
| CEBPA Mutation Analysis (Bi-directional Sequencing) | 81218 | 1 | $ - 0 | |||
| KIT (c-KIT) Mutation Analysis | 81272 | 1 | $ - 0 | |||
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Colorectal NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| CXCR4 Mutation Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| EGFR Mutation Analysis (Bi-directional Sequencing) | 81235 | 1 | $ - 0 | |||
| EGFR vIII Analysis | 81479 | 1 | $ - 0 | |||
| ERBB2 Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| FLT3 (ITD & IKD) Mutation Analysis | 81479 | 1 | $ - 0 | |||
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | 81246 | 1 | $ - 0 | |||
| IDH1 and IDH2 Mutations Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| IgVH Mutation Analysis | 81263 | 1 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 10 | $ - 0 | |||
| JAK2 V617F with reflex to EXON 12-14 Mutation Analysis (Bi-Directional Seq) | 81270, 81279 | 10 | $ - 0 | |||
| KRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Lung Complete NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Lung Limited NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| MET Exon 14 Deletion Analysis | 81479 | 1 | $ - 0 | |||
| MicroSatellite Instability Analysis (MSI)(Fragment Length Analysis) | 81301 | 1 | $ - 0 | |||
| MLH1 Promoter Methylation Analysis | 81288 | 1 | $ - 0 | |||
| MPN Extended Reflex Panel | 81479 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 5 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 5 | $ - 0 | |||
| CALR Mutation Analysis | 81219 | 1 | $ - 0 | |||
| MPL Mutation Analysis (Bi-directional Sequencing) | 81339 | 2 | $ - 0 | |||
| NTRK NGS Fusion Panel | 81194 | 1 | $ - 0 | |||
| NTRK & RET NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| Non-Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| NOTCH1 Mutation Analysis (Fragment Length Analysis) | 81407 | 1 | $ - 0 | |||
| NPM1 Mutation Analysis (Fragment Length Analysis) | 81310 | 1 | $ - 0 | |||
| NRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| PML-RARA Translocation, t(15;17) | 81315 | 1 | $ - 0 | |||
| Prostate NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| RAS/RAF Panel | 81479 | 1 | $ - 0 | |||
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | 81401 | 1 | $ - 0 | |||
| Sarcoma Comprehensive NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| STAT3 Mutation Analysis | 81405 | 1 | $ - 0 | |||
| Targeted Solid Tumor NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Thyroid NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| TP53 Mutation Analysis (Bi-Directional Sequencing) | 81352 | 1 | $ - 0 | |||
| Universal Solid Tumor NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| $ - 0 | ||||||
| 1 | $ - 0 | |||||
| Hematologic Profiles (Molecular Only) | $ - 0 | |||||
| NeoTYPE™ ALL Prognostic Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Discovery Profile for Hematologic Cancers | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Follicular Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Lymphoid Disorders Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| NeoTYPE™ Cholangiocarcinoma Profile | 81445 1 | 1 | $ - 0 | |||
| NeoTYPE Lung Tumor Profile | 81479 1 | 1 | $ - 0 | |||
| NeoTYPETM (or equivalent) Global | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE CLL Prognostic Profile | 81479, 88374x4 | 1 | $ - 0 | |||
| NeoTYPE ALL Profile | 81450, 88374x2 | 1 | $ - 0 | |||
| NeoTYPE™ Myeloid Disorders Profile | 81455 | 1 | $ - 0 | Global Only, replaces Myeloid Disorders Profile | ||
| NeoTYPE MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoTYPETM (4) (or equivalent) Technical Only | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE ALL Profile | 81450, 88374TCx2 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoLABTM (or equivalent) LIQUID BIOPSY | $ - 0 | |||||
| $ - 0 | ||||||
| SPECIMEN HOLD OPTIONS | $ - 0 | |||||
| Cytogenetics | $ - 0 | |||||
| Culture and Hold | 1 | $ - 0 | ||||
| FISH | $ - 0 | |||||
| Direct Harvest and Hold for FISH | 1 | $ - 0 | ||||
| Molecular Testing | $ - 0 | |||||
| Freeze and Hold | 1 | $ - 0 | ||||
| Extract Nucleic Acid and Hold | 1 | $ - 0 |
| Miscellanous Testing - not listed above | |
| TOTAL | |
| $ - 0 |
Order Period 3
| Order Period 3: 04/01/2026-03/31/2027 | |||||
| Test Name | CPT/s | Units | Estimated Quantity | Unit Price | Total Est Price |
FLOW CYTOMETRY
| 10 COLOR FLOW CYTOMETRY | ||||||
| 10 Color Flow Cytometry - General Pricing | ||||||
| TC Flow Cytometry 1st marker | 88184 | 1 | 100 | $ - 0 | ||
| Additional Markers | 88185 | 23 | 50 | $ - 0 | *Standard Panel has 23 additional markers, so this should be taken into consideration when calculating | |
| Flow Interpretation (2-8 Markers) | 88187 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (9-15 Markers) | 88188 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (16+ Markers) | 88189 | 1 | 50 | $ - 0 | ||
| $ - 0 | ||||||
| 10 Color Flow Cytometry Special Pricing | $ - 0 | |||||
| Flow Profile PNH Tech (8) | 88184, 88185 | 8 | 1 | $ - 0 | ||
| Flow Profile DNA Global | 88182 | 1 | 1 | $ - 0 | ||
| $ - 0 | ||||||
| $ - 0 | ||||||
| CYTOGENETICS | $ - 0 | |||||
| Chromosome Analysis (Set Up) | 88237 or 88230 or 88233 or 88239 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis (Cell Analysis) | 88261, 88262, or 88264 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis Interpretation | 88291 | 1 | 1 | $ - 0 | ||
| Additional Karyotypes | 88280 | 1 | 1 | $ - 0 | ||
| Additional Cells | 88285 | 1 | 1 | $ - 0 | ||
| Additional Culture | 88237 or 88239 | 1 | 1 | $ - 0 | ||
| No Growth | 88230, 88233, 88237, or 88239 | 1 | 1 | $ - 0 | ||
| FISH | $ - 0 | |||||
| MANUAL | $ - 0 | |||||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | 88368PC | 5 | $ - 0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | 88368TC | 5 | $ - 0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | 88368 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | 88369TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 88369PC | 5 | $ - 0 | |||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | 88369 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | 88377TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | 88377PC | 5 | $ - 0 | |||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | 88377 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| AUTOMATED | $ - 0 | |||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | 88367TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | 88367PC | 5 | $ - 0 | |||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | 88367 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | 88373TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | 88373PC | 5 | $ - 0 | |||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | 88373 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | 88374TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | 88374PC | 5 | $ - 0 | |||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | 88374 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| $ - 0 | ||||||
| ANATOMIC PATHOLOGY (3) | $ - 0 | |||||
| Special Stain | 88312 | 10 | $ - 0 | |||
| Special Stain Tech | 88312TC | 10 | $ - 0 | |||
| Tissue Special Stain | 88313 | 10 | $ - 0 | |||
| Tissue Special Stain Tech | 88313TC | 10 | $ - 0 | |||
| Professional Consult | 88323 | 5 | $ - 0 | |||
| Professional Consult Tech | 88323TC | 5 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure | 88341 | 10 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure Tech | 88341TC | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain | 88342 | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain Tech | 88342TC | 10 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | 88360 | 1 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | 88360TC | 1 | $ - 0 | |||
| IHC Quantitative | 88360 | 10 | $ - 0 | |||
| IHC Quantitative Tech | 88360TC | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Glo | 88361 | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Tech | 88361TC | 10 | $ - 0 | |||
| IHC by ISH | 88365/ 88364 | 10 | $ - 0 | |||
| IHC by ISH TC | 88365TC/ 88364TC | 10 | $ - 0 | |||
| MOLECULAR PATHOLOGY TESTING (3) | $ - 0 | |||||
| ALK Mutation Analysis | 81479 | 1 | $ - 0 | |||
| BCR-ABL1 Standard p210,p190 | 81479 | 5 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Major (p210) for CML | 81206 | 1 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Minor (p210) for ALL | 81207 | 1 | $ - 0 | |||
| BCR-ABL1 Non-Standard p230 | 81208 | 1 | $ - 0 | |||
| T-Cell Receptor Beta Gene Rearrangement | 81340 | 1 | $ - 0 | |||
| B&T-Cell Gene Rearrangement (Fragment Length Analysis) | 81479 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGH | 81261 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGK | 81264 | 1 | $ - 0 | |||
| T-Cell Receptor Gamma Gene Rearrangement | 81342 | 1 | $ - 0 | |||
| BCL-1 Translocation t(11:14) | 81168 | 1 | $ - 0 | |||
| BCL-2 Translocation t(14;18) | 81278 | 1 | $ - 0 | |||
| BRAF Mutation Analysis (Bi-directional Sequencing) | 81210 | 1 | $ - 0 | |||
| Brain NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BRCA1/2 Mutation Analysis for Tumors | 81163 | 1 | $ - 0 | |||
| Breast NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BTK Mutation Analysis (single gene assay) | 81233 | 1 | $ - 0 | |||
| BTK Inhibitor Acquired Resistance Panel | 81479 | 1 | $ - 0 | |||
| CEBPA Mutation Analysis (Bi-directional Sequencing) | 81218 | 1 | $ - 0 | |||
| KIT (c-KIT) Mutation Analysis | 81272 | 1 | $ - 0 | |||
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Colorectal NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| CXCR4 Mutation Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| EGFR Mutation Analysis (Bi-directional Sequencing) | 81235 | 1 | $ - 0 | |||
| EGFR vIII Analysis | 81479 | 1 | $ - 0 | |||
| ERBB2 Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| FLT3 (ITD & IKD) Mutation Analysis | 81479 | 1 | $ - 0 | |||
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | 81246 | 1 | $ - 0 | |||
| IDH1 and IDH2 Mutations Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| IgVH Mutation Analysis | 81263 | 1 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 10 | $ - 0 | |||
| JAK2 V617F with reflex to EXON 12-14 Mutation Analysis (Bi-Directional Seq) | 81270, 81279 | 10 | $ - 0 | |||
| KRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Lung Complete NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Lung Limited NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| MET Exon 14 Deletion Analysis | 81479 | 1 | $ - 0 | |||
| MicroSatellite Instability Analysis (MSI)(Fragment Length Analysis) | 81301 | 1 | $ - 0 | |||
| MLH1 Promoter Methylation Analysis | 81288 | 1 | $ - 0 | |||
| MPN Extended Reflex Panel | 81479 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 5 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 5 | $ - 0 | |||
| CALR Mutation Analysis | 81219 | 1 | $ - 0 | |||
| MPL Mutation Analysis (Bi-directional Sequencing) | 81339 | 2 | $ - 0 | |||
| NTRK NGS Fusion Panel | 81194 | 1 | $ - 0 | |||
| NTRK & RET NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| Non-Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| NOTCH1 Mutation Analysis (Fragment Length Analysis) | 81407 | 1 | $ - 0 | |||
| NPM1 Mutation Analysis (Fragment Length Analysis) | 81310 | 1 | $ - 0 | |||
| NRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| PML-RARA Translocation, t(15;17) | 81315 | 1 | $ - 0 | |||
| Prostate NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| RAS/RAF Panel | 81479 | 1 | $ - 0 | |||
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | 81401 | 1 | $ - 0 | |||
| Sarcoma Comprehensive NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| STAT3 Mutation Analysis | 81405 | 1 | $ - 0 | |||
| Targeted Solid Tumor NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Thyroid NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| TP53 Mutation Analysis (Bi-Directional Sequencing) | 81352 | 1 | $ - 0 | |||
| Universal Solid Tumor NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| $ - 0 | ||||||
| 1 | $ - 0 | |||||
| Hematologic Profiles (Molecular Only) | $ - 0 | |||||
| NeoTYPE™ ALL Prognostic Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Discovery Profile for Hematologic Cancers | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Follicular Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Lymphoid Disorders Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| NeoTYPE™ Cholangiocarcinoma Profile | 81445 1 | 1 | $ - 0 | |||
| NeoTYPE Lung Tumor Profile | 81479 1 | 1 | $ - 0 | |||
| NeoTYPETM (or equivalent) Global | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE CLL Prognostic Profile | 81479, 88374x4 | 1 | $ - 0 | |||
| NeoTYPE ALL Profile | 81450, 88374x2 | 1 | $ - 0 | |||
| NeoTYPE™ Myeloid Disorders Profile | 81455 | 1 | $ - 0 | Global Only, replaces Myeloid Disorders Profile | ||
| NeoTYPE MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoTYPETM (4) (or equivalent) Technical Only | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE ALL Profile | 81450, 88374TCx2 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoLABTM (or equivalent) LIQUID BIOPSY | $ - 0 | |||||
| $ - 0 | ||||||
| SPECIMEN HOLD OPTIONS | $ - 0 | |||||
| Cytogenetics | $ - 0 | |||||
| Culture and Hold | 1 | $ - 0 | ||||
| FISH | $ - 0 | |||||
| Direct Harvest and Hold for FISH | 1 | $ - 0 | ||||
| Molecular Testing | $ - 0 | |||||
| Freeze and Hold | 1 | $ - 0 | ||||
| Extract Nucleic Acid and Hold | 1 | $ - 0 |
| Miscellanous Testing - not listed above | |
| TOTAL | |
| $ - 0 |
Order Period 4
| Order Period 4: 04/01/2027-03/31/2028 | |||||
| Test Name | CPT/s | Units | Estimated Quantity | Unit Price | Total Est Price |
FLOW CYTOMETRY
| 10 COLOR FLOW CYTOMETRY | ||||||
| 10 Color Flow Cytometry - General Pricing | ||||||
| TC Flow Cytometry 1st marker | 88184 | 1 | 100 | $ - 0 | ||
| Additional Markers | 88185 | 23 | 50 | $ - 0 | *Standard Panel has 23 additional markers, so this should be taken into consideration when calculating | |
| Flow Interpretation (2-8 Markers) | 88187 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (9-15 Markers) | 88188 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (16+ Markers) | 88189 | 1 | 50 | $ - 0 | ||
| $ - 0 | ||||||
| 10 Color Flow Cytometry Special Pricing | $ - 0 | |||||
| Flow Profile PNH Tech (8) | 88184, 88185 | 8 | 1 | $ - 0 | ||
| Flow Profile DNA Global | 88182 | 1 | 1 | $ - 0 | ||
| $ - 0 | ||||||
| $ - 0 | ||||||
| CYTOGENETICS | $ - 0 | |||||
| Chromosome Analysis (Set Up) | 88237 or 88230 or 88233 or 88239 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis (Cell Analysis) | 88261, 88262, or 88264 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis Interpretation | 88291 | 1 | 1 | $ - 0 | ||
| Additional Karyotypes | 88280 | 1 | 1 | $ - 0 | ||
| Additional Cells | 88285 | 1 | 1 | $ - 0 | ||
| Additional Culture | 88237 or 88239 | 1 | 1 | $ - 0 | ||
| No Growth | 88230, 88233, 88237, or 88239 | 1 | 1 | $ - 0 | ||
| FISH | $ - 0 | |||||
| MANUAL | $ - 0 | |||||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | 88368PC | 5 | $ - 0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | 88368TC | 5 | $ - 0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | 88368 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | 88369TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 88369PC | 5 | $ - 0 | |||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | 88369 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | 88377TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | 88377PC | 5 | $ - 0 | |||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | 88377 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| AUTOMATED | $ - 0 | |||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | 88367TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | 88367PC | 5 | $ - 0 | |||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | 88367 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | 88373TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | 88373PC | 5 | $ - 0 | |||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | 88373 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | 88374TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | 88374PC | 5 | $ - 0 | |||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | 88374 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| $ - 0 | ||||||
| ANATOMIC PATHOLOGY (3) | $ - 0 | |||||
| Special Stain | 88312 | 10 | $ - 0 | |||
| Special Stain Tech | 88312TC | 10 | $ - 0 | |||
| Tissue Special Stain | 88313 | 10 | $ - 0 | |||
| Tissue Special Stain Tech | 88313TC | 10 | $ - 0 | |||
| Professional Consult | 88323 | 5 | $ - 0 | |||
| Professional Consult Tech | 88323TC | 5 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure | 88341 | 10 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure Tech | 88341TC | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain | 88342 | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain Tech | 88342TC | 10 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | 88360 | 1 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | 88360TC | 1 | $ - 0 | |||
| IHC Quantitative | 88360 | 10 | $ - 0 | |||
| IHC Quantitative Tech | 88360TC | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Glo | 88361 | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Tech | 88361TC | 10 | $ - 0 | |||
| IHC by ISH | 88365/ 88364 | 10 | $ - 0 | |||
| IHC by ISH TC | 88365TC/ 88364TC | 10 | $ - 0 | |||
| MOLECULAR PATHOLOGY TESTING (3) | $ - 0 | |||||
| ALK Mutation Analysis | 81479 | 1 | $ - 0 | |||
| BCR-ABL1 Standard p210,p190 | 81479 | 5 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Major (p210) for CML | 81206 | 1 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Minor (p210) for ALL | 81207 | 1 | $ - 0 | |||
| BCR-ABL1 Non-Standard p230 | 81208 | 1 | $ - 0 | |||
| T-Cell Receptor Beta Gene Rearrangement | 81340 | 1 | $ - 0 | |||
| B&T-Cell Gene Rearrangement (Fragment Length Analysis) | 81479 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGH | 81261 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGK | 81264 | 1 | $ - 0 | |||
| T-Cell Receptor Gamma Gene Rearrangement | 81342 | 1 | $ - 0 | |||
| BCL-1 Translocation t(11:14) | 81168 | 1 | $ - 0 | |||
| BCL-2 Translocation t(14;18) | 81278 | 1 | $ - 0 | |||
| BRAF Mutation Analysis (Bi-directional Sequencing) | 81210 | 1 | $ - 0 | |||
| Brain NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BRCA1/2 Mutation Analysis for Tumors | 81163 | 1 | $ - 0 | |||
| Breast NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BTK Mutation Analysis (single gene assay) | 81233 | 1 | $ - 0 | |||
| BTK Inhibitor Acquired Resistance Panel | 81479 | 1 | $ - 0 | |||
| CEBPA Mutation Analysis (Bi-directional Sequencing) | 81218 | 1 | $ - 0 | |||
| KIT (c-KIT) Mutation Analysis | 81272 | 1 | $ - 0 | |||
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Colorectal NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| CXCR4 Mutation Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| EGFR Mutation Analysis (Bi-directional Sequencing) | 81235 | 1 | $ - 0 | |||
| EGFR vIII Analysis | 81479 | 1 | $ - 0 | |||
| ERBB2 Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| FLT3 (ITD & IKD) Mutation Analysis | 81479 | 1 | $ - 0 | |||
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | 81246 | 1 | $ - 0 | |||
| IDH1 and IDH2 Mutations Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| IgVH Mutation Analysis | 81263 | 1 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 10 | $ - 0 | |||
| JAK2 V617F with reflex to EXON 12-14 Mutation Analysis (Bi-Directional Seq) | 81270, 81279 | 10 | $ - 0 | |||
| KRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Lung Complete NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Lung Limited NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| MET Exon 14 Deletion Analysis | 81479 | 1 | $ - 0 | |||
| MicroSatellite Instability Analysis (MSI)(Fragment Length Analysis) | 81301 | 1 | $ - 0 | |||
| MLH1 Promoter Methylation Analysis | 81288 | 1 | $ - 0 | |||
| MPN Extended Reflex Panel | 81479 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 5 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 5 | $ - 0 | |||
| CALR Mutation Analysis | 81219 | 1 | $ - 0 | |||
| MPL Mutation Analysis (Bi-directional Sequencing) | 81339 | 2 | $ - 0 | |||
| NTRK NGS Fusion Panel | 81194 | 1 | $ - 0 | |||
| NTRK & RET NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| Non-Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| NOTCH1 Mutation Analysis (Fragment Length Analysis) | 81407 | 1 | $ - 0 | |||
| NPM1 Mutation Analysis (Fragment Length Analysis) | 81310 | 1 | $ - 0 | |||
| NRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| PML-RARA Translocation, t(15;17) | 81315 | 1 | $ - 0 | |||
| Prostate NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| RAS/RAF Panel | 81479 | 1 | $ - 0 | |||
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | 81401 | 1 | $ - 0 | |||
| Sarcoma Comprehensive NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| STAT3 Mutation Analysis | 81405 | 1 | $ - 0 | |||
| Targeted Solid Tumor NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Thyroid NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| TP53 Mutation Analysis (Bi-Directional Sequencing) | 81352 | 1 | $ - 0 | |||
| Universal Solid Tumor NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| $ - 0 | ||||||
| 1 | $ - 0 | |||||
| Hematologic Profiles (Molecular Only) | $ - 0 | |||||
| NeoTYPE™ ALL Prognostic Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Discovery Profile for Hematologic Cancers | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Follicular Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Lymphoid Disorders Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| NeoTYPE™ Cholangiocarcinoma Profile | 81445 1 | 1 | $ - 0 | |||
| NeoTYPE Lung Tumor Profile | 81479 1 | 1 | $ - 0 | |||
| NeoTYPETM (or equivalent) Global | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE CLL Prognostic Profile | 81479, 88374x4 | 1 | $ - 0 | |||
| NeoTYPE ALL Profile | 81450, 88374x2 | 1 | $ - 0 | |||
| NeoTYPE™ Myeloid Disorders Profile | 81455 | 1 | $ - 0 | Global Only, replaces Myeloid Disorders Profile | ||
| NeoTYPE MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoTYPETM (4) (or equivalent) Technical Only | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE ALL Profile | 81450, 88374TCx2 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoLABTM (or equivalent) LIQUID BIOPSY | $ - 0 | |||||
| $ - 0 | ||||||
| SPECIMEN HOLD OPTIONS | $ - 0 | |||||
| Cytogenetics | $ - 0 | |||||
| Culture and Hold | 1 | $ - 0 | ||||
| FISH | $ - 0 | |||||
| Direct Harvest and Hold for FISH | 1 | $ - 0 | ||||
| Molecular Testing | $ - 0 | |||||
| Freeze and Hold | 1 | $ - 0 | ||||
| Extract Nucleic Acid and Hold | 1 | $ - 0 |
| Miscellanous Testing - not listed above | |
| TOTAL | |
| $ - 0 |
Order Period 5
| Order Period 5 : 04/01/2028-03/31/2029 | |||||
| Test Name | CPT/s | Units | Estimated Quantity | Unit Price | Total Est Price |
FLOW CYTOMETRY
| 10 COLOR FLOW CYTOMETRY | ||||||
| 10 Color Flow Cytometry - General Pricing | ||||||
| TC Flow Cytometry 1st marker | 88184 | 1 | 100 | $ - 0 | ||
| Additional Markers | 88185 | 23 | 50 | $ - 0 | *Standard Panel has 23 additional markers, so this should be taken into consideration when calculating | |
| Flow Interpretation (2-8 Markers) | 88187 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (9-15 Markers) | 88188 | 1 | 50 | $ - 0 | ||
| Flow Interpretation (16+ Markers) | 88189 | 1 | 50 | $ - 0 | ||
| $ - 0 | ||||||
| 10 Color Flow Cytometry Special Pricing | $ - 0 | |||||
| Flow Profile PNH Tech (8) | 88184, 88185 | 8 | 1 | $ - 0 | ||
| Flow Profile DNA Global | 88182 | 1 | 1 | $ - 0 | ||
| $ - 0 | ||||||
| $ - 0 | ||||||
| CYTOGENETICS | $ - 0 | |||||
| Chromosome Analysis (Set Up) | 88237 or 88230 or 88233 or 88239 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis (Cell Analysis) | 88261, 88262, or 88264 | 1 | 1 | $ - 0 | ||
| Chromosome Analysis Interpretation | 88291 | 1 | 1 | $ - 0 | ||
| Additional Karyotypes | 88280 | 1 | 1 | $ - 0 | ||
| Additional Cells | 88285 | 1 | 1 | $ - 0 | ||
| Additional Culture | 88237 or 88239 | 1 | 1 | $ - 0 | ||
| No Growth | 88230, 88233, 88237, or 88239 | 1 | 1 | $ - 0 | ||
| FISH | $ - 0 | |||||
| MANUAL | $ - 0 | |||||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | 88368PC | 5 | $ - 0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | 88368TC | 5 | $ - 0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | 88368 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | 88369TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 88369PC | 5 | $ - 0 | |||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | 88369 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | 88377TC | 5 | $ - 0 | |||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | 88377PC | 5 | $ - 0 | |||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | 88377 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| AUTOMATED | $ - 0 | |||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | 88367TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | 88367PC | 5 | $ - 0 | |||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | 88367 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | 88373TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | 88373PC | 5 | $ - 0 | |||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | 88373 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | 88374TC | 5 | $ - 0 | |||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | 88374PC | 5 | $ - 0 | |||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | 88374 | 10 | $ - 0 | |||
| $ - 0 | ||||||
| $ - 0 | ||||||
| ANATOMIC PATHOLOGY (3) | $ - 0 | |||||
| Special Stain | 88312 | 10 | $ - 0 | |||
| Special Stain Tech | 88312TC | 10 | $ - 0 | |||
| Tissue Special Stain | 88313 | 10 | $ - 0 | |||
| Tissue Special Stain Tech | 88313TC | 10 | $ - 0 | |||
| Professional Consult | 88323 | 5 | $ - 0 | |||
| Professional Consult Tech | 88323TC | 5 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure | 88341 | 10 | $ - 0 | |||
| IHC Qualitative; addn'l stain procedure Tech | 88341TC | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain | 88342 | 10 | $ - 0 | |||
| IHC Qualitative; per specimen; initial single antibody stain Tech | 88342TC | 10 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | 88360 | 1 | $ - 0 | |||
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | 88360TC | 1 | $ - 0 | |||
| IHC Quantitative | 88360 | 10 | $ - 0 | |||
| IHC Quantitative Tech | 88360TC | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Glo | 88361 | 10 | $ - 0 | |||
| IHC Morphometric Analysis, computer assist, Tech | 88361TC | 10 | $ - 0 | |||
| IHC by ISH | 88365/ 88364 | 10 | $ - 0 | |||
| IHC by ISH TC | 88365TC/ 88364TC | 10 | $ - 0 | |||
| MOLECULAR PATHOLOGY TESTING (3) | $ - 0 | |||||
| ALK Mutation Analysis | 81479 | 1 | $ - 0 | |||
| BCR-ABL1 Standard p210,p190 | 81479 | 5 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Major (p210) for CML | 81206 | 1 | $ - 0 | |||
| quantitative BCR/ABL, t (9;22) Minor (p210) for ALL | 81207 | 1 | $ - 0 | |||
| BCR-ABL1 Non-Standard p230 | 81208 | 1 | $ - 0 | |||
| T-Cell Receptor Beta Gene Rearrangement | 81340 | 1 | $ - 0 | |||
| B&T-Cell Gene Rearrangement (Fragment Length Analysis) | 81479 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGH | 81261 | 1 | $ - 0 | |||
| B-Cell Gene Rearrangement - IGK | 81264 | 1 | $ - 0 | |||
| T-Cell Receptor Gamma Gene Rearrangement | 81342 | 1 | $ - 0 | |||
| BCL-1 Translocation t(11:14) | 81168 | 1 | $ - 0 | |||
| BCL-2 Translocation t(14;18) | 81278 | 1 | $ - 0 | |||
| BRAF Mutation Analysis (Bi-directional Sequencing) | 81210 | 1 | $ - 0 | |||
| Brain NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BRCA1/2 Mutation Analysis for Tumors | 81163 | 1 | $ - 0 | |||
| Breast NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| BTK Mutation Analysis (single gene assay) | 81233 | 1 | $ - 0 | |||
| BTK Inhibitor Acquired Resistance Panel | 81479 | 1 | $ - 0 | |||
| CEBPA Mutation Analysis (Bi-directional Sequencing) | 81218 | 1 | $ - 0 | |||
| KIT (c-KIT) Mutation Analysis | 81272 | 1 | $ - 0 | |||
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Colorectal NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| CXCR4 Mutation Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| EGFR Mutation Analysis (Bi-directional Sequencing) | 81235 | 1 | $ - 0 | |||
| EGFR vIII Analysis | 81479 | 1 | $ - 0 | |||
| ERBB2 Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| FLT3 (ITD & IKD) Mutation Analysis | 81479 | 1 | $ - 0 | |||
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | 81246 | 1 | $ - 0 | |||
| IDH1 and IDH2 Mutations Analysis (Bi-directional Sequencing) | 81479 | 1 | $ - 0 | |||
| IgVH Mutation Analysis | 81263 | 1 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 10 | $ - 0 | |||
| JAK2 V617F with reflex to EXON 12-14 Mutation Analysis (Bi-Directional Seq) | 81270, 81279 | 10 | $ - 0 | |||
| KRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| Lung Complete NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Lung Limited NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| MET Exon 14 Deletion Analysis | 81479 | 1 | $ - 0 | |||
| MicroSatellite Instability Analysis (MSI)(Fragment Length Analysis) | 81301 | 1 | $ - 0 | |||
| MLH1 Promoter Methylation Analysis | 81288 | 1 | $ - 0 | |||
| MPN Extended Reflex Panel | 81479 | 1 | $ - 0 | |||
| JAK2 EXON 12-14 Mutation Analysis (Bi-directional Seq) | 81279 | 5 | $ - 0 | |||
| JAK2 V617F Mutation Analysis | 81270 | 5 | $ - 0 | |||
| CALR Mutation Analysis | 81219 | 1 | $ - 0 | |||
| MPL Mutation Analysis (Bi-directional Sequencing) | 81339 | 2 | $ - 0 | |||
| NTRK NGS Fusion Panel | 81194 | 1 | $ - 0 | |||
| NTRK & RET NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| Non-Ewing Sarcoma NGS Fusion Panel | 81479 | 1 | $ - 0 | |||
| NOTCH1 Mutation Analysis (Fragment Length Analysis) | 81407 | 1 | $ - 0 | |||
| NPM1 Mutation Analysis (Fragment Length Analysis) | 81310 | 1 | $ - 0 | |||
| NRAS Mutation Analysis | 81479 | 1 | $ - 0 | |||
| PML-RARA Translocation, t(15;17) | 81315 | 1 | $ - 0 | |||
| Prostate NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| RAS/RAF Panel | 81479 | 1 | $ - 0 | |||
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | 81401 | 1 | $ - 0 | |||
| Sarcoma Comprehensive NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| STAT3 Mutation Analysis | 81405 | 1 | $ - 0 | |||
| Targeted Solid Tumor NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| Thyroid NGS Fusion Panel | 81445 | 1 | $ - 0 | |||
| TP53 Mutation Analysis (Bi-Directional Sequencing) | 81352 | 1 | $ - 0 | |||
| Universal Solid Tumor NGS Fusion Panel | 81455 | 1 | $ - 0 | |||
| $ - 0 | ||||||
| 1 | $ - 0 | |||||
| Hematologic Profiles (Molecular Only) | $ - 0 | |||||
| NeoTYPE™ ALL Prognostic Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Discovery Profile for Hematologic Cancers | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Follicular Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE® Lymphoid Disorders Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ Lymphoma Profile | 81450 | 1 | $ - 0 | |||
| NeoTYPE™ MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| NeoTYPE™ Cholangiocarcinoma Profile | 81445 1 | 1 | $ - 0 | |||
| NeoTYPE Lung Tumor Profile | 81479 1 | 1 | $ - 0 | |||
| NeoTYPETM (or equivalent) Global | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE CLL Prognostic Profile | 81479, 88374x4 | 1 | $ - 0 | |||
| NeoTYPE ALL Profile | 81450, 88374x2 | 1 | $ - 0 | |||
| NeoTYPE™ Myeloid Disorders Profile | 81455 | 1 | $ - 0 | Global Only, replaces Myeloid Disorders Profile | ||
| NeoTYPE MDS/CMML Profile | 81450 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoTYPETM (4) (or equivalent) Technical Only | $ - 0 | |||||
| Hematologic Profiles | $ - 0 | |||||
| NeoTYPE ALL Profile | 81450, 88374TCx2 | 1 | $ - 0 | |||
| Solid Tumor Profiles | $ - 0 | |||||
| $ - 0 | ||||||
| NeoLABTM (or equivalent) LIQUID BIOPSY | $ - 0 | |||||
| $ - 0 | ||||||
| SPECIMEN HOLD OPTIONS | $ - 0 | |||||
| Cytogenetics | $ - 0 | |||||
| Culture and Hold | 1 | $ - 0 | ||||
| FISH | $ - 0 | |||||
| Direct Harvest and Hold for FISH | 1 | $ - 0 | ||||
| Molecular Testing | $ - 0 | |||||
| Freeze and Hold | 1 | $ - 0 | ||||
| Extract Nucleic Acid and Hold | 1 | $ - 0 |
| Miscellanous Testing - not listed above | |
| TOTAL | |
| $ - 0 |
File details come from the government source that posted it. Updated .